Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Astellas Pharma Singapore Pte. Ltd.

Clinical trials sponsored by Astellas Pharma Singapore Pte. Ltd., explained in plain language.

Now part of Astellas Pharma Inc. 4503 TOKYO

A subsidiary of Astellas Pharma, a global pharmaceutical company, focusing on regional operations.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Could gilteritinib keep AML in remission longer after transplant?

Knowledge-focused Completed

This study looked at people with a type of leukemia (AML) that has a FLT3 gene change, which makes the cancer grow faster. After a stem cell transplant, some patients took the drug gilteritinib in earlier trials, while others received standard care. Researchers compared medical r…

Sponsor: Astellas Pharma Singapore Pte. Ltd. • Aim: Knowledge-focused

Last updated Jun 26, 2026 15:35 UTC